4//SEC Filing
Lin Xichen 4
Accession 0001415889-24-015683
CIK 0001888886other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 7:38 PM ET
Size
16.4 KB
Accession
0001415889-24-015683
Insider Transaction Report
Form 4
Lin Xichen
CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
American Depositary Shares
2024-06-03$45.00/sh−17,700$796,500→ 17,700 total→ Ordinary Shares (53,100 underlying) - Conversion
Ordinary Shares
2024-06-03−106,200→ 85,707 total - Sale
American Depositary Shares
2024-06-03$50.00/sh−17,700$885,071→ 0 total→ Ordinary Shares (53,100 underlying) - Exercise/Conversion
Ordinary Shares
2024-06-03$0.34/sh+106,200$36,108→ 191,907 total - Exercise/Conversion
Share Option (right to buy)
2024-06-03−106,200→ 213,800 totalExercise: $0.34Exp: 2029-09-10→ Ordinary Shares (106,200 underlying) - Conversion
American Depositary Shares
2024-06-03+35,400→ 35,400 total→ Ordinary Shares (106,200 underlying)
Footnotes (7)
- [F1]The Ordinary Shares were converted into American Depositary Shares as reported in Table II above.
- [F2]1/4 of the shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
- [F3]This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 106,200 Ordinary Shares.
- [F4]Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.
- [F5]106,200 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 35,400 American Depositary Shares.
- [F6]The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023.
- [F7]The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Documents
Issuer
Structure Therapeutics Inc.
CIK 0001888886
Entity typeother
Related Parties
1- filerCIK 0001962926
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 7:38 PM ET
- Size
- 16.4 KB